Cargando…

Immunotherapy Advances for Epithelial Ovarian Cancer

SIMPLE SUMMARY: The overall five-year survival rate in epithelial ovarian cancer is 44% and has only marginally improved in the past two decades. Despite an initial response to standard treatment consisting of chemotherapy and surgical removal of tumor, the lesions invariably recur, and patients ult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartnett, Erin G., Knight, Julia, Radolec, Mackenzy, Buckanovich, Ronald J., Edwards, Robert P., Vlad, Anda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764119/ https://www.ncbi.nlm.nih.gov/pubmed/33322601 http://dx.doi.org/10.3390/cancers12123733

Ejemplares similares

Interdisciplinary Approach for the Medical Management of Gestational Gigantomastia
por: Cabrera, Camila, et al.
Publicado: (2020)

CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary
por: Bai, Shoumei, et al.
Publicado: (2019)

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
por: Mantia-Smaldone, Gina M, et al.
Publicado: (2010)

Progestins: Pro-senescence therapy for ovarian cancer?
por: Oesterreich, Steffi, et al.
Publicado: (2013)

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
por: Pavicic, Paul G., et al.
Publicado: (2023)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

BMPs morph into new roles in ovarian cancer
por: McLean, Karen, et al.
Publicado: (2013)

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2013)

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition
por: Cascio, Sandra, et al.
Publicado: (2021)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer
por: Taylor, Sarah E., et al.
Publicado: (2022)

Validation of LRG1 as a Potential Biomarker for Detection of Epithelial Ovarian Cancer by a Blinded Study
por: Wu, Jing, et al.
Publicado: (2015)

The role of surgery in advanced epithelial ovarian cancer
por: Martín-Cameán, María, et al.
Publicado: (2016)

Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
por: Palaia, Innocenza, et al.
Publicado: (2020)

PD-L1 biology in response to chemotherapy in vitro and in vivo in ovarian cancer
por: Grabosch, Shannon, et al.
Publicado: (2015)

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition
por: Ni, Ying, et al.
Publicado: (2021)

Immunotherapy in Ovarian Cancer
por: Siminiak, Natalia, et al.
Publicado: (2022)

Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases
por: Winer, Ira, et al.
Publicado: (2009)

Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial to mesenchymal transition in ovarian cancer
por: Zhang, Lixin, et al.
Publicado: (2016)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma
por: Ezzati, Mohammad, et al.
Publicado: (2014)

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer
por: Capellero, S., et al.
Publicado: (2020)

Adoptive immunotherapy against ovarian cancer
por: Mittica, Gloria, et al.
Publicado: (2016)

Application Of Adoptive Immunotherapy In Ovarian Cancer
por: Yang, Siyu, et al.
Publicado: (2019)

Ovarian Cancer Immunotherapy and Personalized Medicine
por: Morand, Susan, et al.
Publicado: (2021)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Immunotherapy in Melanoma: Recent Advances and Future Directions
por: Knight, Andrew, et al.
Publicado: (2023)

Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy
por: Suarez Mora, Adria, et al.
Publicado: (2022)

The prognostic value of morphometry in advanced epithelial ovarian cancers.
por: Katsoulis, M., et al.
Publicado: (1995)

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
por: Borella, Fulvio, et al.
Publicado: (2023)

Advancements in Cancer Immunotherapies
por: Roy, Ruchi, et al.
Publicado: (2022)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Ovarian cancer immunotherapy: opportunities, progresses and challenges
por: Liu, Bei, et al.
Publicado: (2010)

Ovarian Cancer Immunotherapy: Turning up the Heat
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives
por: Awada, Ahmad, et al.
Publicado: (2022)

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis
por: Fan, Huihui, et al.
Publicado: (2020)

Quinary debulking for epithelial ovarian cancer
por: Edwards, James M., et al.
Publicado: (2012)

Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fpfgrh5461hlvk85uaicpibekh